News
Videos
Conferences
Events
Resources
Subscribe

News|Videos|April 20, 2016

Clinical Trials and Stem Cell Transplants

Episodes in this series

EP. 1 Types of Multiple Myeloma

EP. 1 Types of Multiple Myeloma

EP. 2 Testing Procedures and Considerations

EP. 2 Testing Procedures and Considerations

EP. 3 Considerations For Treatment

EP. 3 Considerations For Treatment

EP. 4 Monitoring Patients

EP. 4 Monitoring Patients

EP. 5 Top Considerations for Maintenance Therapy

EP. 5 Top Considerations for Maintenance Therapy

EP. 6 New Drug Classes For Treatment

EP. 6 New Drug Classes For Treatment

EP. 7 Clinical Trials and Stem Cell Transplants

EP. 7 Clinical Trials and Stem Cell Transplants

EP. 8 Professional Expectations for Future

EP. 8 Professional Expectations for Future

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Myelofibrosis Survivor Reflects on the Impact of Her Physician

Myelofibrosis Survivor Reflects on the Impact of Her Physician

ByMayra Andujar-Delgado

December 28th 2025

Oya Gilbert

Advice for Patients Newly Diagnosed With Multiple Myeloma

December 27th 2025

image of man.

A Five-Time Cancer Survivor’s Advice for Patients

December 27th 2025

Orserdu plus Verzenio or Afinitor was well tolerated and showed early signs of effectiveness in advanced ER+/HER2– breast cancer: © stock.adobe.com.

Orserdu Combo Shows Potential for ER+/HER2– Breast Cancer

ByCourtney Flaherty

December 26th 2025

A woman.

Advice for Patients Newly Diagnosed With Lung Cancer

ByPatricia I. Moreno

December 26th 2025

Trending on CURE

Top 5 Breast Cancer Updates From the 2025 San Antonio Breast Cancer Symposium

Advice for Patients Newly Diagnosed With Multiple Myeloma

A Five-Time Cancer Survivor’s Advice for Patients

Orserdu Combo Shows Potential for ER+/HER2– Breast Cancer

Omitting Sentinel Lymph Node Biopsy Safe in Older Breast Cancer